The 2017 International Arceci Award funds two researchers

2017 Int Arceci Award

This year, the St. Baldrick’s Foundation for childhood cancers congratulates the two winners of the Robert J. Arceci Innovation Award: Dr. Franck Bourdeaut from the Curie Institute in Paris, and PD Dr. Jan-Henning Klusmann from the Hannover Medical School. Read more

Dr Sam Behjati awarded first International Robert J. Arceci Innovation Award

SIOP 2016 St Baldrick Winner

Dr Sam Behjati, Research Fellow in Medical Sciences (Corpus Christi College Cambridge, UK), has become the first recipient of the International Robert J. Arceci Innovation Award for his work helping children with cancer.

St. Baldrick's Foundation Robert J. Arceci Innovation Award

The St. Baldrick’s Foundation supports annual nominations for a unique award in loving memory of Dr. Bob Arceci. Nominations for the 2018 award will be available at a later date.

Two Robert J. Arceci Innovation Awards will be made per year, one to a U.S. or Canadian researcher to be presented at the  annual ASPHO meeting, and one international award to be presented at the SIOP meeting.

Each award is $250,000 per year for three years, to support truly innovative childhood cancer research. The award reflects Bob’s values, including thinking outside the box, international research, and development of the next generation of scientists. St. Baldrick’s Foundation is funding the award, which was developed in collaboration with the leadership of SIOP, ASPHO and the COG.

This award is based on nominations, not applications, for early- to mid-career researchers.

Nominations are accepted annually. Please check the SIOP webpage for updates on the next deadline for applications.

Nominations made by members of SIOP, ASPHO and the COG will be considered by the Selection Committee.

Among other criteria, each nominee must work in a research environment with mentoring and support conducive of continued academic success and innovation; have presented, published, or received funding for highly innovative research with the potential to lead to critical discoveries or major advancements that will accelerate important advances in our understanding of childhood cancer; and have demonstrated participation in team science, in addition to success in innovative discovery.

Make a donation

To make a donation in memory of Bob and support this award, please give online or send a check (“Arceci Hero Fund” in the memo line) to:

Becky Chapman Weaver, St. Baldrick’s Foundation, 1333 S. Mayflower Ave., Ste. 400, Monrovia, CA 91016.


St. Baldrick's Foundation Presents First of its Kind Award in Honor of Renowned Researcher




MINNEAPOLIS, May 13, 2016 /PRNewswire-USNewswire/ — The St. Baldrick’s Foundation, the largest private funder of childhood cancer research grants, awarded Charles Mullighan, MBBS (Hons), MSc, MD, the first-ever St. Baldrick’s Foundation Robert J. Arceci Innovation Award at today’s American Society of Pediatric Hematology/Oncology (ASHPO) conference.

This one-of-a-kind award was created in memory of renowned oncologist Dr. Robert J. Arceci, known as “Bob” to those close to him. Dr. Arceci served as director of the Children’s Center for Cancer and Blood Hematology and Oncology and co-director of the Ronald A. Matricaria Institute of Molecular Medicine at Phoenix Children’s Hospital in Arizona. He treated countless children; was an international authority in many areas of pediatric cancer research; he developed groundbreaking documentaries to educate the public about the realities of childhood cancers; and was the editor of the only international medical journal devoted to childhood cancer research, “Pediatric Blood & Cancer.” As a member of the St. Baldrick’s board and chair of the Scientific Advisory Committee, Dr. Arceci had supported the idea of a new type of funding, but before conversations could take place, he died in a hit-and-run motorcycle accident.
“It is no small feat to do justice to Bob’s memory and the impact he made on the childhood cancer community. The opportunity to honor his legacy in the form of something that continues his innovative work and offers hope to the children he dedicated his life to, is a beautiful thing to be part of,” said Kathleen Ruddy, CEO of the St. Baldrick’s Foundation. “Looking to the future, we are excited to see what’s next and are fully confident in Dr. Mullighan’s passion, approach and innovative research.”

For information on nomination criteria and the process, please email Becky Chapman Weaver.